These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2239121)

  • 21. Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial.
    Jenkins IR; Dolman J; O'Connor JP; Ansley DM
    Anaesth Intensive Care; 1997 Jun; 25(3):245-9. PubMed ID: 9209604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hemodynamic effects of amrinone during emergence from cardiopulmonary bypass].
    Nakata F; Ka H; Yamamoto H; Nammpo T; Yoshikawa H
    Masui; 1995 Dec; 44(12):1632-8. PubMed ID: 8583658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical and hemodynamic multicenter study of the effect of intravenous amrinone in the treatment of low cardiac output after valvular replacement].
    Estanove S; Lehot JJ; Bastien O; Demortière P; Bompard D; Clerc J; Flamens C
    Ann Cardiol Angeiol (Paris); 1988; 37(7):393-7. PubMed ID: 3064697
    [No Abstract]   [Full Text] [Related]  

  • 24. Amrinone, in combination with norepinephrine, is an effective first-line drug for difficult separation from cardiopulmonary bypass.
    Hardy JF; Searle N; Roy M; Perrault J
    Can J Anaesth; 1993 Jun; 40(6):495-501. PubMed ID: 8403112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effects of amrinone and colloid administration in children following cardiac surgery.
    Lynn AM; Sorensen GK; Williams GD; Anderson GD; Opheim KE
    J Cardiothorac Vasc Anesth; 1993 Oct; 7(5):560-5. PubMed ID: 8268437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inotropic support of the heart that fails to successfully wean from cardiopulmonary bypass: the Montreal Heart Institute experience.
    Hardy JF; Belisle S
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):33-9. PubMed ID: 8103681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early intervention of inotropic support in facilitating weaning from cardiopulmonary bypass: the New England Deaconess Hospital experience.
    Lewis KP
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):40-5. PubMed ID: 8369467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of amrinone on oxygen demand-supply relationship after cardiopulmonary bypass in patient undergoing coronary bypass surgery].
    Sha K; Shimokawa M; Kawaguchi M; Sakamoto T; Nishimura K; Kaneko M; Kitaguchi K; Furuya H
    Masui; 1997 May; 46(5):635-9. PubMed ID: 9185460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The choice of inotropes following cardiopulmonary bypass. Con: amrinone is not a first-choice inotrope following cardiopulmonary bypass.
    Estafanous FG
    J Cardiothorac Vasc Anesth; 1991 Apr; 5(2):184-6. PubMed ID: 1863733
    [No Abstract]   [Full Text] [Related]  

  • 30. Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery.
    Novitzky D; Cooper DK; Swanepoel A
    Eur J Cardiothorac Surg; 1989; 3(2):140-5. PubMed ID: 2627465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical applications of amrinone.
    Hines R
    J Cardiothorac Anesth; 1989 Dec; 3(6 Suppl 2):24-32. PubMed ID: 2521048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amrinone before termination of cardiopulmonary bypass: haemodynamic variables and oxygen utilization in the postbypass period.
    Ramsay JG; DeJesus JM; Wynands JE; Ralley FE; O'Connor JP; Robbins GR; Bilodeau J
    Can J Anaesth; 1992 Apr; 39(4):342-8. PubMed ID: 1563059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of active components of amrinone by analysis of pressure-volume results; use of the conductance (volume) catheter technic and rapid load change by balloon occlusion of the inferior vena cava].
    Thormann J; Kramer W; Kindler M; Kremer P; Schlepper M
    Z Kardiol; 1987 Sep; 76(9):530-40. PubMed ID: 3424908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amrinone, platelets, and the balloon pump.
    MacGillivray RG; Shama DM
    J Cardiothorac Anesth; 1988 Apr; 2(2):268. PubMed ID: 17171922
    [No Abstract]   [Full Text] [Related]  

  • 35. An amrinone bolus prior to weaning from cardiopulmonary bypass improves cardiac function in mitral valve surgery patients.
    Badner NH; Murkin JM; Shannon NA
    J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):410-4. PubMed ID: 7948796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differences in hemodynamic effects of amrinone, milrinone and olprinon after cardiopulmonary bypass in valvular cardiac surgery].
    Sha K; Shimokawa M; Ishimaru K; Kawaraguchi Y; Takahashi M; Yanaidani F; Kitaguchi K; Furuya H
    Masui; 2000 Sep; 49(9):981-6. PubMed ID: 11025952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW; Woods WL; Davila-Roman VG; Morello PJ; Kurz H; Barbarash R; Spinner L; Sperry J; Beckham V; Coulter L
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative experience with amrinone.
    Levy JH; Bailey JM
    Eur J Anaesthesiol Suppl; 1992; 5():15-9. PubMed ID: 1600963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of amrinone on the right side of the heart.
    Hess W
    J Cardiothorac Anesth; 1989 Dec; 3(6 Suppl 2):38-44. PubMed ID: 2521050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amrinone: is it the inotrope of choice?
    Wynands JE
    J Cardiothorac Anesth; 1989 Dec; 3(6 Suppl 2):45-57. PubMed ID: 2521051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.